Harvard, Tufts med students stage protest at ‘biased’ $2.9B drug development figure

Ben Adams Around two dozen students from Harvard Medical School and Tufts University as well as members of health activist groups protested in front of the Tufts Center for the Study ...

Tufts joins AstraZeneca’s virtual CNS drug development team

John Carroll AstraZeneca has enlisted Tufts University's School of Medicine in its virtual campaign to develop new drugs in the neurosciences field. FierceBiotech News

Tufts: New Neglected Diseases Drug Approvals has Nearly Doubled

mia.burns Number of Annual New Drug Approvals to Treat Neglected Diseases Has Nearly Doubled Between the Early-2000s and 2009-12, According to the Tufts Center for the Study of Drug ...
© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS